Product Images Risedronate Sodium

Once-a-Week Risedronate Sodium Tablets, USP are available in a 4-week supply with 4 tablets per bottle.*

Risedronate is a prescription drug available in a package of 30 film-coated tablets, each containing the equivalent of 5 mg of anhydrous risedronate sodium, USP, in the form of the monohydrate. The usual dosage should be taken as directed by a prescriber, and the full prescribing information is available in the package insert. The medication should be stored at a controlled temperature and protected from light and moisture. The bottle has a child-resistant closure as required by USP, and it is important to keep all medications out of reach of children. This medication was made for Teva Pharmaceuticals and is manufactured in Kfar Saba, 4410202, Israel.*

Risedronate is a prescription medication that comes in the form of a fin-coated tablet containing 30mg of anhydrous risedronate Sodium, USP. It is dispensed by pharmacists using the NDC 0093-3100-56 code and comes with an accompanying Medication Guide for patients. The medication is intended to be taken as directed by the prescriber, with dosage information provided in the package insert. Risedronate should be stored at a controlled room temperature between 20-25°C (68-77°F) and dispensed in a tight, light-resistant container. The medication is manufactured by Teva Pharmaceuticals and should be kept out of reach of children. The text also includes manufacture and serialization coding information.*